Michel Carlos Tommo Tchouaket

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

Joseph Fokam, Alex Durand Nka, Flore Yollande Mamgue Dzukam et al. · Medicine · 2023 · 22 citations · Full text

Antiviral Drug, Covid-19, Pediatric Epidemiology +20

Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon

Aissatou Abba, Joseph Fokam, Rachel Simo Kamgaing et al. · PLoS ONE · 2021 · 21 citations · Full text

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

Ezéchiel Ngoufack Jagni Semengue, Joseph Fokam, Naomi-Karell Etame et al. · Viruses · 2022 · 20 citations · Full text

Hiv Viral Load, Immunodeficiencies, Antiviral Drug +17

Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness

Alex Durand Nka, Yagaï Bouba, Joseph Fokam et al. · Frontiers in Public Health · 2024 · 19 citations · Full text

Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon

Samuel Martin Sosso, Michel Carlos Tommo Tchouaket, Joseph Fokam et al. · Virology Journal · 2020 · 14 citations · Full text